WHO experts on Thursday criticized the slow pace of European vaccination and said the increase in coronavirus infections was “worrying.” The World Health Organization (WHO) emphasizes that the spread of the disease is currently accelerating worldwide and the death toll is high. WHO; mentioned that the virus could currently increase the risk of new, growing strains
WHO Director-General for Europe, Hans Kluge, said the slow pace of vaccination in Europe was “prolonging the catastrophe.” The vaccine shows how best we can get rid of this contagious disease … However, the emergence of these vaccines is unacceptable and slow,”Kluge said in a statement.
A report published on the WHO website said “Last week saw an increase in the transmission of COVID-19 in the majority of countries in the WHO European Region, with 1.6 million new cases and close to 24 000 deaths. The Region remains the second most affected by SARS-CoV-2 of all the world’s regions, with the total number of deaths fast approaching 1 million and the total number of cases about to surpass 45 million.”
The WHO has criticized Europe for slowing the delivery of vaccines and increasing the effects of Covic 19 in the second wave. The emergence of vaccines in Europe is “unacceptable and slow,” the World Health Organization said Wednesday, assessing Covid’s response in the region, amid growing “concerns” about infections.
On the other hand many European countries have struggled to implement effective vaccination programs as pharmaceutical companies routinely deliver planned shipments The region has vaccinated only 10% of its population with a single injection, the WHO said in a statement.
“Vaccines show the best way to get rid of this contagious disease. Not only do they work, they are also very effective in preventing infection. However, the production of these vaccines is unacceptable and slow. , “WHO Director for Europe Dr. Kluge said in a statement.
The report also said that only 16% of people in the EU have so far received a dose of the vaccine. The EU has been slow to negotiate a contract with AstraZeneca Vaccine Company which has led to logistical problems. It has also sparked a political dispute with the United Kingdom, where AstraZeneca has a plant where 52% of the population has taken at least one measure.